局部晚期肺癌调强放疗的剂量学优势
结果显示IMRT降低肺、心脏和食管的 incidental 剂量,靶区覆盖等效,可能改善治疗耐受性。
要点
- IMRT降低肺V20 Gy和平均肺剂量,且不增加V5 Gy。
- IMRT改善心脏V5,但V30 Gy无差异。
- IMRT改善食管所有剂量学终点,靶区覆盖等效。
核心结论
- IMRT在靶区覆盖等效的前提下显著降低肺、心脏和食管的不必要剂量,可能改善治疗耐受性。
研究设计与样本
- 计划按靶区覆盖归一,标准剂量60 Gy/2 Gy,部分患者接受选择性淋巴结照射44 Gy/2 Gy。
主要发现
- 肺V20 Gy为21.5% vs 26.5%(P < .01),平均肺剂量为11.9 Gy vs 14.9 Gy(P < .01),V5 Gy无增加(P = .76)。
- 心脏V5为28.9% vs 33.7%(P < .01),V30 Gy为9.8% vs 15.9%(P = .10)。
- 食管所有剂量学终点(V20 Gy、V45 Gy、V60 Gy、平均剂量)均改善,例如V60为6.5% vs 21%(P < .01)。
临床怎么用
- 对于局部晚期肺癌根治性放疗,IMRT可作为降低肺、心脏和食管剂量的技术选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy plays an essential role in the treatment of locally advanced lung cancer, but it inevitably leads to incidental and unnecessary dose to critical organs, including the lung, heart, and esophagus. Numerous radiation dose-volumetric parameters have been associated with increased risk of morbidity and mortality. The purpose of the present study is to quantify differences in normal tissue radiation exposure with intensity modulated radiation therapy (IMRT) compared with 3-dimensional conformal radiation therapy (3D-CRT). METHODS AND MATERIALS: Twenty-four consecutive patients with locally advanced lung cancer undergoing definitive IMRT were enrolled on a phase 1 protocol. For each patient, an optimized 3D-CRT plan was also designed. Plans were normalized in terms of planning target coverage with a standard dose of 60 Gy in 2-Gy fractions with a subset of patients also receiving elective nodal irradiation to a dose of 44 Gy in 2-Gy fractions. Normal tissue dosimetric comparisons were made for the lung, heart, and esophagus. RESULTS: IMRT decreased incidental dose to the lungs, heart, and esophagus. For lung, both V20 Gy (21.5% vs 26.5%, P < .01) and mean lung dose (11.9 Gy vs 14.9 Gy, P < .01) were improved with IMRT without a corresponding increase in V5 Gy (P = .76). For heart, there was improvement in V5 (28.9% vs 33.7%, P < .01) but no difference in V30 Gy (9.8% vs 15.9%. P = .10). For esophagus, all dosimetric endpoints were improved (V20 Gy, V45 Gy, V60 Gy, mean dose). For example, V60 was 6.5% with IMRT compared with 21% with 3D-CRT (P < .01). CONCLUSIONS: IMRT significantly decreased unnecessary dose to critical organs with equivalent coverage of planning target volumes. IMRT may therefore improve the tolerability of therapy.
引用
- Boyle J, Ackerson B, Gu L, et al. Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer. Adv Radiat Oncol. 2017. PMID: 28740910. doi:10.1016/j.adro.2016.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。